Proton pump inhibitor-induced erythema dyschromicum perstans-like pigmentation.

Gutierrez, Daniel; Krueger, Loren D; Tan, Andrea; Park, Joyce H; Lipkin, George; Meehan, Shane A

Gutierrez, Daniel; Krueger, Loren D; Tan, Andrea; Park, Joyce H; Lipkin, George; Meehan, Shane A.

Afiliación

Gutierrez D; Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York.
Krueger LD; Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York.
Tan A; Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York.
Park JH; University of Texas Southwestern Medical Center, Dallas, Texas.
Lipkin G; Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York.
Meehan SA; Kaiser Permanente San Jose Medical Center, San Jose, California.

JAAD Case Rep ; 5(8): 701-703, 2019 Aug.

Article en En | MEDLINE | ID: mdl-31440561

Palabras clave

AD, ashy dermatosis; EDP, erythema dyschromicum perstans; PPI, proton pump inhibitor; ashy dermatosis; drug-induced pigmentation; erythema dyschromicum perstans; esomeprazole; lansoprazole

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: JAAD Case Rep Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google